Johnson & Johnson (ETR:JNJ)
134.46
-1.12 (-0.83%)
Jul 11, 2025, 1:26 PM CET
Johnson & Johnson Revenue
Johnson & Johnson had revenue of $21.89B USD in the quarter ending March 30, 2025, with 2.39% growth. This brings the company's revenue in the last twelve months to $89.33B, up 4.30% year-over-year. In the year 2024, Johnson & Johnson had annual revenue of $88.82B with 4.30% growth.
Revenue (ttm)
$89.33B
Revenue Growth
+4.30%
P/S Ratio
3.94
Revenue / Employee
$646.86K
Employees
138,100
Market Cap
324.63B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 88.82B | 3.66B | 4.30% |
Dec 31, 2023 | 85.16B | 5.17B | 6.46% |
Jan 1, 2023 | 79.99B | 1.25B | 1.59% |
Jan 2, 2022 | 78.74B | -3.84B | -4.65% |
Jan 3, 2021 | 82.58B | 525.00M | 0.64% |
Dec 29, 2019 | Pro | Pro | Pro |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jan 1, 2017 | Pro | Pro | Pro |
Jan 3, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.49B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.17B |
Johnson & Johnson News
- 1 day ago - P/E Ratio Insights for Johnson & Johnson - Benzinga
- 1 day ago - Johnson & Johnson's Outlook Clouded By $2 Billion Headwind - Benzinga
- 1 day ago - Johnson & Johnson's Outlook Clouded By $2 Billion Headwind - Benzinga
- 1 day ago - Johnson & Johnson: What To Expect From The Upcoming Q2 Earnings? - Seeking Alpha
- 2 days ago - Johnson & Johnson to report Q2 earnings on July 16. Here’s what to expect - AlphaStreet
- 2 days ago - Trump threatens impose up to 200% tariff on pharmaceuticals 'very soon' - CNBC
- 2 days ago - Healthy Returns: Medicaid cuts in Trump's megabill may affect some drugmakers more than others - CNBC
- 2 days ago - Johnson & Johnson seeks FDA nod for expanded use of Capylta - Seeking Alpha